Research programme: NISV therapeutic - Protherics

Drug Profile

Research programme: NISV therapeutic - Protherics

Alternative Names: NISV therapeutic research programme - Protherics

Latest Information Update: 24 Jul 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Protherics
  • Class
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 24 Jul 2003 Discontinued - Phase-I for Rheumatoid arthritis in United Kingdom (SC)
  • 06 Sep 2002 The NISV therapeutics are available for licensing []
  • 16 Dec 1997 Phase-I clinical trials for Rheumatoid arthritis in United Kingdom (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top